FTSE Factsheet
Total Page:16
File Type:pdf, Size:1020Kb
FTSE COMPANY REPORT Share price analysis relative to sector and index performance Arix Bioscience ARIX Investment Banking and Brokerage Services — GBP 1.76 at close 18 June 2021 Absolute Relative to FTSE UK All-Share Sector Relative to FTSE UK All-Share Index PERFORMANCE 18-Jun-2021 18-Jun-2021 18-Jun-2021 2.5 220 250 1D WTD MTD YTD Absolute -4.9 -1.1 -0.6 -19.6 200 Rel.Sector -3.1 1.6 0.4 -21.3 Rel.Market -3.2 0.5 -0.2 -26.2 2 200 180 VALUATION 160 1.5 150 Trailing 140 Relative Price Relative Price Relative PE 1.9 Absolute Price (local currency) (local Price Absolute 120 1 100 EV/EBITDA -ve 100 PB 0.7 PCF -ve 0.5 80 50 Div Yield 0.0 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Price/Sales +ve Absolute Price 4-wk mov.avg. 13-wk mov.avg. Relative Price 4-wk mov.avg. 13-wk mov.avg. Relative Price 4-wk mov.avg. 13-wk mov.avg. Net Debt/Equity 0.0 100 90 100 Div Payout 0.0 90 80 90 ROE 47.6 80 70 80 70 Index) Share Share Sector) Share - - 70 60 60 DESCRIPTION 60 50 50 50 The principal activity of the Company is to source, 40 40 RSI RSI (Absolute) 40 finance and develop healthcare and life science 30 businesses globally. 30 20 30 10 20 20 RSI (Relative to FTSE UKFTSE All to RSI (Relative RSI (Relative to FTSE UKFTSE All to RSI (Relative 0 10 10 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Past performance is no guarantee of future results. Please see the final page for important legal disclosures. 1 of 4 FTSE COMPANY REPORT: Arix Bioscience 18 June 2021 Valuation Metrics Price to Earnings (PE) EV to EBITDA Price to Book (PB) 31-May-2021 31-May-2021 31-May-2021 6 1 4.5 0.9 4 5 +1SD 0.8 3.5 0.7 +1SD 4 3 0.6 2.5 3 Avg 0.5 2 0.4 Avg 2 1.5 0.3 0.2 1 1 -1SD 0.1 0.5 -1SD 0 ‖ ‖ ‖ ‖ 0 ‖ ‖ 0 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 JTC 75.5 Intermediate Capital Group 82.9 AJ Bell 15.9 Liontrust Asset Management 71.5 AJ Bell 32.1 City Of London Investment Group 14.4 Sanne Group 64.3 Liontrust Asset Management 29.4 Hargreaves Lansdown 14.1 Intermediate Capital Group 56.1 Sanne Group 24.7 Integrafin Holdings 12.8 AJ Bell 44.8 JTC 23.8 Liontrust Asset Management 10.5 Investment Banking and Brokerage Services 12.3 Investment Banking and Brokerage Services 6.8 Investment Banking and Brokerage Services 1.9 Georgia Capital 3.6 Quilter 1.8 Real Estate Credit Investments 1.0 Arix Bioscience 1.9 Allied Minds 0.0 IP Group 1.0 Allied Minds -1.4 Arix Bioscience 0.0 Standard Life Aberdeen 0.9 Real Estate Credit Investments -19.2 Real Estate Credit Investments 0.0 Arix Bioscience 0.7 John Laing Group -30.1 John Laing Group 0.0 Georgia Capital 0.6 -40 -20 0 20 40 60 80 100 0 10 20 30 40 50 60 70 80 90 0 2 4 6 8 10 12 14 16 18 Price to Cash Flow (PCF) Dividend Yield % Price to Sales (PS) 31-May-2021 31-May-2021 1 16 ‖ ‖ 0.9 14 0.8 12 0.7 0.6 10 0.5 8 0.4 6 0.3 4 0.2 0.1 2 0 0 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Intermediate Capital Group 80.0 Real Estate Credit Investments 8.2 Arix Bioscience 15.0 Standard Life Aberdeen 80.0 Plus500 7.5 Allied Minds 15.0 Liontrust Asset Management 49.0 M&G 7.5 John Laing Group 15.0 AJ Bell 44.6 Jupiter Fund Management 6.2 3i Group 15.0 Rathbone Brothers 33.3 Standard Life Aberdeen 5.3 Integrafin Holdings 15.0 Investment Banking and Brokerage Services 14.9 Investment Banking and Brokerage Services 3.8 XPS Pensions Group 2.3 John Laing Group -22.8 John Laing Group 1.4 Investment Banking and Brokerage Services 1.9 Arix Bioscience -35.6 JTC 1.0 TP ICAP Group 0.9 IP Group -48.3 IP Group 0.8 St. James's Place 0.9 St. James's Place -60.4 Arix Bioscience 0.0 Quilter 0.6 Georgia Capital -100.0 Allied Minds 0.0 M&G 0.4 -120 -100 -80 -60 -40 -20 0 20 40 60 80 100 0 1 2 3 4 5 6 7 8 9 0 2 4 6 8 10 12 14 16 Note: bar chart reflects the top and bottom five current values for the valuation ratio in question for FTSE All Shares stocks in the same sector as the stock concerned. All valuation metrics are trailing. 2 of 4 FTSE COMPANY REPORT: Arix Bioscience 18 June 2021 Valuation Metrics Net Debt to Equity Dividend Payout (DP) Return on Equity (RoE) 31-May-2021 31-May-2021 31-May-2021 0.005 1 50 0.9 0.004 0.8 40 0.7 +1SD 0.003 0.6 30 0.5 0.002 0.4 20 Avg 0.3 0.001 0.2 10 0.1 -1SD 0 ‖‖ 0 0 ‖ ‖ ‖ ‖ Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Intermediate Capital Group 4.1 Intermediate Capital Group 100.0 Plus500 50.0 M&G 1.5 XPS Pensions Group 100.0 Ninety One Plc 50.0 Sanne Group 1.0 River and Mercantile Group 100.0 Hargreaves Lansdown 50.0 JTC 0.9 Liontrust Asset Management 100.0 Arix Bioscience 47.6 Rathbone Brothers TP ICAP Group 0.6 100.0 City Of London Investment Group 40.0 Investment Banking and Brokerage Services 46.2 Investment Banking and Brokerage Services 0.5 Investment Banking and Brokerage Services 16.5 IP Group 0.0 Hargreaves Lansdown XPS Pensions Group 0.0 Georgia Capital 0.0 4.8 Plus500 0.0 Arix Bioscience 0.0 Quilter 4.5 Ashmore Group 0.0 Allied Minds 0.0 John Laing Group -4.1 Arix Bioscience 0.0 John Laing Group 0.0 Real Estate Credit Investments -5.9 Georgia Capital 0.0 Real Estate Credit Investments 0.0 Allied Minds -50.0 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 0 20 40 60 80 100 120 -60 -40 -20 0 20 40 60 ROE vs. PB — sector Du Pont Analysis 18 scatter 150 60 16 AJB 100 50 CLIG 14 HL. IHP 50 40 12 LIO 10 0 30 PB N91 8 -50 20 STJ 6 SNN JTC CMCX ICP -100 10 4 PLUS IGG RIV BRW ASHM EMG SDR 2 XPSRAT JUP Investment Banki JLG QLT III -150 0 RECIALM TCAP IPO MNG ‖ ‖ SLA CGEO ARIX 2017 2018 2019 2020 2021 0 0 10 20 30 40 50 60 Net Margin Asset Turnover Gearing ROE (rhs) ‖ ROE Note: bar chart reflects the top and bottom five current values for the valuation ratio in question for FTSE All Shares stocks in the same sector as the stock concerned. All valuation metrics are trailing. 3 of 4 FTSE COMPANY REPORT: Arix Bioscience 18 June 2021 Brief description Brief description Price to Earnings Price to Earnings (PE) is price over earnings per share. Earnings are based on the latest Gearing Gearing is Total Assets divided by Common Equity. Total Assets and Common Equity are (PE) available fiscal year earnings. each averaged over two years, that is, t and (t-1). Price to Sales (PS) Price to Sales (PS) is price divided by sales per share. It is based on sales from continuing Asset Turnover Asset turnover is Sales divided by Total Assets. Total Assets is averaged over two years, operations for the fiscal year. that is, t and (t-1). Price to Book (PB) Price to Book (PB) is price at the indicated date divided by common equity per share. Dupont Breakdown Return on Equity (RoE) = Net Margin * Gearing * Asset Turnover Common/ordinary equity is generally as reported at the most recent fiscal year-end but is Analysis adjusted to exclude minority interest, preferred stock and selected items as appropriate. RoE vs PB Plot of RoE versus PB at last month end for all FTSE UK All Share stocks in the sector Price to Cash Flow Price to Cash Flow (PCF) is price at the indicated date divided by cash flow per share. relative to the stock in question. Data may be limited to the stock in question if there are (PCF) currently no stocks in the corresponding FTSE UK All Share sector. Net Debt Equity Net Debt Equity is Net Debt as a percentage of common equity. Not calculated if Absolute Absolute graphs reflect performance for the stock in question for up to 366 days adjusted denominator (common equity) is negative for intervening corporate actions.